DE69904208T2 - Antioxidative mischung bestehend aus acetyl l-carnitin und alpha-liponsäure - Google Patents

Antioxidative mischung bestehend aus acetyl l-carnitin und alpha-liponsäure

Info

Publication number
DE69904208T2
DE69904208T2 DE69904208T DE69904208T DE69904208T2 DE 69904208 T2 DE69904208 T2 DE 69904208T2 DE 69904208 T DE69904208 T DE 69904208T DE 69904208 T DE69904208 T DE 69904208T DE 69904208 T2 DE69904208 T2 DE 69904208T2
Authority
DE
Germany
Prior art keywords
carnitin
antioxidative
acetyl
alpha
mixture composed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69904208T
Other languages
English (en)
Other versions
DE69904208D1 (de
DE69904208T3 (de
Inventor
Claudio Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau HealthScience SpA
Original Assignee
Sigma Tau HealthScience SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11406116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69904208(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sigma Tau HealthScience SpA filed Critical Sigma Tau HealthScience SpA
Publication of DE69904208D1 publication Critical patent/DE69904208D1/de
Publication of DE69904208T2 publication Critical patent/DE69904208T2/de
Application granted granted Critical
Publication of DE69904208T3 publication Critical patent/DE69904208T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
DE69904208T 1998-09-01 1999-08-19 Antioxidative mischung bestehend aus acetyl l-carnitin und alpha-liponsäure Expired - Lifetime DE69904208T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1998RM000566A IT1302307B1 (it) 1998-09-01 1998-09-01 Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
ITRM980566 1998-09-01
PCT/IT1999/000268 WO2000011968A1 (en) 1998-09-01 1999-08-19 ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID

Publications (3)

Publication Number Publication Date
DE69904208D1 DE69904208D1 (de) 2003-01-09
DE69904208T2 true DE69904208T2 (de) 2003-08-28
DE69904208T3 DE69904208T3 (de) 2010-09-30

Family

ID=11406116

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69904208T Expired - Lifetime DE69904208T3 (de) 1998-09-01 1999-08-19 Antioxidative mischung bestehend aus acetyl l-carnitin und alpha-liponsäure

Country Status (28)

Country Link
US (1) US6365622B1 (de)
EP (1) EP1112005B2 (de)
JP (1) JP4361215B2 (de)
KR (1) KR20010079699A (de)
CN (1) CN1315835A (de)
AR (1) AR022076A1 (de)
AT (1) ATE228312T1 (de)
AU (1) AU773424B2 (de)
BR (1) BR9913288A (de)
CA (1) CA2341973C (de)
CZ (1) CZ2001541A3 (de)
DE (1) DE69904208T3 (de)
DK (1) DK1112005T4 (de)
EE (1) EE200100113A (de)
ES (1) ES2188214T5 (de)
HK (1) HK1039730A1 (de)
HU (1) HU229165B1 (de)
IL (1) IL141435A0 (de)
IS (1) IS5850A (de)
IT (1) IT1302307B1 (de)
MA (1) MA25284A1 (de)
NO (1) NO20010954L (de)
PL (1) PL212737B1 (de)
PT (1) PT1112005E (de)
SK (1) SK2632001A3 (de)
TN (1) TNSN99163A1 (de)
TR (1) TR200100610T2 (de)
WO (1) WO2000011968A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10258239A1 (de) * 2002-12-13 2004-06-24 Degussa Ag Formulierung enthaltend alpha-Liponsäure(-Derivate) als alleinigen Wirkstoff bei nichtchronischen alkoholinduzierten Intoxikationen

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562869B1 (en) 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
WO2001021208A1 (en) 1999-09-23 2001-03-29 Juvenon Corporation Nutritional supplement for increased energy and stamina
US6335361B1 (en) * 1999-11-03 2002-01-01 Juvenon Inc. Method of treating benign forgetfulness
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
DE10036797A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Verwendung von Kombinationen mit einem Gehalt an Carnitinen
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
JP2010142237A (ja) * 2000-10-31 2010-07-01 Colgate Palmolive Co 組成物及び方法
US20020076470A1 (en) * 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
CA2427470A1 (en) * 2000-10-31 2002-06-06 Colgate-Palmolive Company Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin c or vitamin e for preventing or inhibiting loss of cognitive function
US6555573B2 (en) 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
WO2002071874A2 (en) * 2001-03-09 2002-09-19 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
SE0102380D0 (sv) * 2001-07-02 2001-07-02 Macronova Ab Kräm för behandling av åldersförändringar i huden hos människa
US6923960B2 (en) * 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
WO2003053336A2 (en) * 2001-12-19 2003-07-03 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
US20060127505A1 (en) * 2002-01-16 2006-06-15 David Haines Anti-inflammatory formulations
EP1476440A4 (de) * 2002-02-22 2005-06-01 Albany College Of Pharmacy Verfahren und verbindungen, die sich zur inhibierung von oxidativen schädigungen und/oder schädigungen durch freie radikale und zur behandlung und prävention von krankheiten eignen
EP1558199A4 (de) * 2002-10-11 2006-06-28 Creagri Inc Therapeutische kombination von carnitin undpolyphenol-antioxidantien
US7083813B2 (en) 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
US20040265345A1 (en) * 2003-06-30 2004-12-30 Perricone Nicholas V. Treatment of skin damage using acetyl carnitine and lipoic acid
US7999003B2 (en) 2003-08-26 2011-08-16 Mannatech, Incorporated Antioxidant compositions and methods thereto
US20050214413A1 (en) * 2003-08-26 2005-09-29 Mannatech, Inc. Methods and compositions for modified release of nutritional supplements
AU2003300167B2 (en) 2003-12-31 2010-09-16 K-Pax Vitamins, Inc. Nutrient compositions and methods for enhanced effectiveness of the immune system
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
WO2006058278A2 (en) * 2004-11-24 2006-06-01 Hill's Pet Nutrition, Inc. Methods for improving liver clearance of xenobiotic substances in an animal
JP5138380B2 (ja) * 2004-11-24 2013-02-06 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物における免疫応答を増大させる方法
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
WO2006071919A2 (en) 2004-12-29 2006-07-06 Hill's Pet Nutrition, Inc. Methods for inhibiting a decline in learning and/or memory in animals
US8252742B2 (en) * 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
AU2005322887B2 (en) * 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
JP5685362B2 (ja) * 2005-04-26 2015-03-18 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−Ｔａｕ Ｉｎｄｕｓｔｒｉｅ Ｆａｒｍａｃｅｕｔｉｃｈｅ Ｒｉｕｎｉｔｅ Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ 有痛性末梢糖尿病性神経障害の予防のためのアセチルｌ−カルニチン
EP1906912B1 (de) 2005-07-14 2012-08-15 Hill's Pet Nutrition, Inc. Verfahren zur verlängerung des lebens von tieren
WO2007095760A1 (en) * 2006-02-23 2007-08-30 Nou Life Sciences, Inc. Cleavable carnitine compound
CN101045048B (zh) * 2006-03-27 2011-05-18 中国科学院上海生命科学研究院 线粒体营养素组合物的应用
CN101057857B (zh) * 2006-04-21 2011-05-18 中国科学院上海生命科学研究院 一种预防与改善帕金森氏症的组合物及其制法
KR100811110B1 (ko) * 2007-02-21 2008-03-06 주식회사 디피아이 솔루션스 수분산성 α-리포산 캡슐 조성물을 함유하는 어류의 면역력증강용 사료첨가제 및 그 사용방법.
US20080226696A1 (en) * 2007-03-15 2008-09-18 Ben Treadwell Methods of improving learning abilities of aged companion animals
KR20090014568A (ko) * 2007-08-06 2009-02-11 (주)바이오제닉스 코팅된 알파리포산 입자, 이를 포함하는 조성물 및 그 제조방법
US20100255109A1 (en) * 2007-08-06 2010-10-07 Biogenics, Inc. Stabilized antioxidant particles, composition comprising the same and method for preparing the same
US7943163B2 (en) * 2007-08-22 2011-05-17 Response Scientific, Inc. Medical food or nutritional supplement, method of manufacturing same, and method of managing diabetes
US20090054513A1 (en) * 2007-08-22 2009-02-26 Response Scientific, Inc. Method of managing blood glucose levels, insulin levels and/or insulin receptor functionality in individuals with diabetes, polycystic ovarian syndrome and/or alzheimer's disease
KR100903549B1 (ko) * 2008-07-29 2009-06-23 주식회사 카이로제닉스 균질한 결정성의 아세틸-ｌ-카르니틴과 티옥트산 칼륨염의 복합염, 이의 제조방법 및 이를 포함하는 약학적 조성물
CA2740338A1 (en) * 2008-11-11 2010-05-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound useful for treating cellulite
EP2389931A1 (de) * 2010-05-21 2011-11-30 Raw Materials Internatinal LLC Wässrige pharmazeutische Zusammensetzungen mit Liponsäure als Antioxidationsmittel
US9040082B2 (en) 2011-06-24 2015-05-26 K-Pax Pharmaceuticals, Inc. Compositions and methods for treatment of chronic fatigue
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
HUE049489T2 (hu) 2011-12-07 2020-09-28 Allergan Inc Hatékony lipidbevitel emberi könnyfilmbe sóérzékeny emulziós rendszer alkalmazásával
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US20140371280A1 (en) * 2013-03-15 2014-12-18 Shinichi Okuyama Method of treating diabetic peripheral neuropathy through amendment of pre-neuronal diabetic coagulative micro-angiopathy and neuronal deficiency of mitochondrial ATP production, and through induction of neuronal regeneration
CA2965671A1 (en) * 2014-10-24 2016-04-28 Robert Shorr Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome
US10279005B2 (en) 2014-11-25 2019-05-07 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
PL3277273T3 (pl) * 2015-03-31 2020-11-02 Kolinpharma S.P.A. Kompozycja do leczenia neuropatii i/lub bólu neuropatycznego
RU2739619C2 (ru) * 2015-08-24 2020-12-28 Витролайф Свиден Аб Культуральная среда
CN111467385B (zh) * 2019-01-24 2022-05-17 深圳市华大农业应用研究院 组合物在预防或治疗神经退行性疾病中的用途
DK3773012T3 (da) * 2019-04-18 2021-09-13 Simo Rasi Sammensætning til anvendelse ved forebyggelse eller reduktion af oxidativt stress og neurodegenerative sygdomme
US20220313644A1 (en) * 2021-04-06 2022-10-06 Celagenex Research (India) Pvt. Ltd. Synergistic composition for potentiating stabilized atp
CN112999220B (zh) * 2021-04-07 2022-12-13 中国人民解放军南部战区总医院 α-硫辛酸在作为和/或制备金属β-内酰胺酶抑制剂中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
AU6482596A (en) * 1995-07-03 1997-02-05 Wilson T. Crandall Transdermal and oral treatment of androgenic alopecia
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US5977162A (en) 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
EP1021177A4 (de) * 1997-02-04 2002-05-15 John V Kosbab Zusammensetzungen und verfahren zur verhütung und behandlung von vaskulär-degeneratieve krankheiten
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5916912A (en) 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10258239A1 (de) * 2002-12-13 2004-06-24 Degussa Ag Formulierung enthaltend alpha-Liponsäure(-Derivate) als alleinigen Wirkstoff bei nichtchronischen alkoholinduzierten Intoxikationen

Also Published As

Publication number Publication date
AU773424B2 (en) 2004-05-27
CA2341973C (en) 2009-05-12
CN1315835A (zh) 2001-10-03
IS5850A (is) 2001-02-16
ES2188214T5 (es) 2010-06-08
IL141435A0 (en) 2002-03-10
ITRM980566A1 (it) 2000-03-01
EP1112005A1 (de) 2001-07-04
WO2000011968A8 (en) 2000-05-11
HUP0102909A3 (en) 2002-12-28
KR20010079699A (ko) 2001-08-22
MA25284A1 (fr) 2001-12-31
IT1302307B1 (it) 2000-09-05
AU5387199A (en) 2000-03-21
WO2000011968A1 (en) 2000-03-09
DE69904208D1 (de) 2003-01-09
PL212737B1 (pl) 2012-11-30
HUP0102909A2 (hu) 2002-03-28
JP4361215B2 (ja) 2009-11-11
JP2002523435A (ja) 2002-07-30
ES2188214T3 (es) 2003-06-16
HK1039730A1 (zh) 2002-05-10
BR9913288A (pt) 2001-05-22
PT1112005E (pt) 2003-03-31
HU229165B1 (en) 2013-09-30
EP1112005B2 (de) 2010-03-24
ATE228312T1 (de) 2002-12-15
EP1112005B1 (de) 2002-11-27
NO20010954L (no) 2001-04-25
TR200100610T2 (tr) 2001-07-23
DK1112005T4 (da) 2010-06-14
NO20010954D0 (no) 2001-02-26
DE69904208T3 (de) 2010-09-30
EE200100113A (et) 2002-06-17
AR022076A1 (es) 2002-09-04
TNSN99163A1 (fr) 2005-11-10
ITRM980566A0 (it) 1998-09-01
DK1112005T3 (da) 2002-12-30
US6365622B1 (en) 2002-04-02
CZ2001541A3 (cs) 2001-09-12
CA2341973A1 (en) 2000-03-09
PL346318A1 (en) 2002-01-28
SK2632001A3 (en) 2001-08-06

Similar Documents

Publication Publication Date Title
DE69904208D1 (de) Antioxidative mischung bestehend aus acetyl l-carnitin und alpha-liponsäure
DE69918233D1 (de) Polymilchsäure zusammensetzung und daraus hergestellter film
IS2325B (is) Örgerðar samsetningar epleróns
DE69934796D1 (de) Bahnen aus isosorbid enthaltenden polyestern
NO20005913L (no) Legemiddelsammensetning
ATE252832T1 (de) Kombinationen aus herbiziden und safenern
DE69918871D1 (de) Zementzusatzmittel und Zementzusammensetzung
LV12624A (lv) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
NO20026001D0 (no) 3'-promedikamenter av 2'-deoksy-<Beta>-L-nukleosider
DE69723398T2 (de) Polyalkylphenoxyaminoalkane und diese enthaltende freibstoffzusammensetzungen
NO984878D0 (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
EE200200393A (et) Glüburiidi ravimkoostis
ID20973A (id) Senyawa-senyawa polietilenimina berat molekul rendah yang dapat ditoleransi secara biologi
HUP0302635A3 (en) Phospholipid derivatives of valproic acid and mixtures thereof
DE69934889D1 (de) Herstellung und reinigung von diboranen
DE60004292D1 (de) Polyalkylpyrrolidine und diese enthaltende Kraftstoffzusammensetzungen
DE69728306D1 (de) Verträglich gemachte Zusammensetzungen aus Polyetherimiden und flüssigkristallinen Polyestern
DE60000671D1 (de) Entwicklungsvorrichtung und Herstellung ihrer Magnetwalze
ATE212225T1 (de) Injizierbare arzneizubereitung bestehend aus paracetamol
DE69826008D1 (de) Mischungen aus polyimiden und elastomeren
PT1087660E (pt) Formulacoes para repelir vermina
PT1140110E (pt) Clatratos de desidroepiandrosterona e correspondentes composicoes farmaceuticas
DE60024476D1 (de) Pedikulizide und veterinärmedizinische zusammensetzungen
DE69902427T2 (de) Hetero-ethynyl-verbindungen und diese enthaltende zusammensetzungen und kosmetika
DE69906633D1 (de) Mischung bestehend aus ein Retinoid und eine Histidinederivate

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings